Skip to search formSkip to main contentSkip to account menu

AS 605240

Known as: AS-605240, AS605240 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Chronic kidney disease (CKD) poses a formidable challenge for public healthcare worldwide as vast majority of patients with CKD… 
2017
2017
With a steady increase in its incidence and lack of curative treatment, type 1 diabetes (T1D) has emerged as a major health… 
2010
2010
PurposeThis work employs pharmacological targeting of phosphoinositide 3-kinases (PI3K) in selected neuroblastoma (NB) tumors… 
2010
2010
To the Editor: We read with interest the article by Siragusa et al1 showing a protective effect of phosphoinositide-3 kinase… 
2009
2009
OBJECTIVE To investigate the therapeutic effect of PI3Kgamma inhibitor AS605240 on autoimmune myocarditis in mice. METHODS BALB… 
2006
2006
Rheumatoid arthritis and systemic lupus erythematosus are autoimmune diseases, which may involve phosphoinositide 3-kinase gamma… 
2005
2005
Small molecules that specifically inhibit PI3Kγ block disease in mouse models of arthritis and lupus (pages 936–943).